just to clear the sequence of the events in next few months:
1. BIT225--‐008: Phase 2 HCV Three--‐Month Dosing Trial, expect to complete recruitment mid--‐2014
2. 12 week treatment with BIT225 in combination with IFN/RBV (in progress)
3. Partner BIT225 for combination with other DAAs in development
4. result from item 1
5. BIT225--‐009: HCV Phase 2 Combination Trial with DAA (proposed)
currently 25mil MC with cash to complete Item 1 to Item 4. I don't know if anyone can recommend me a Phase 2b bio company with this small MC and huge market to enter.
capital raising ahead, page-13
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $18.94M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.1¢ | $46.68K | 2.124M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1089294 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 686481 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |